Randomized phase <scp>II</scp> trial of survivin 2B peptide vaccination for patients with <scp>HLA</scp>‐A24‐positive pancreatic adenocarcinoma

Randomized phase <scp>II</scp> trial of survivin 2B peptide vaccination for patients with <scp>HLA</scp>‐A24‐positive pancreatic adenocarcinoma

The prognosis of advanced pancreatic adenocarcinoma is still extremely poor. This study sought to determine the efficacy of, and immunological response to, peptide vaccination therapy in patients with this disease. In this multicenter randomized phase II study, patients with advanced pancreatic aden...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Główni autorzy: Hiroaki Shima, Giichiro Tsurita, Satoshi Wada, Yoshihiko Hirohashi, Hiroshi Yasui, Hiroshi Hayashi, Takashi Miyakoshi, Kazue Watanabe, Aiko Murai, Hiroko Asanuma, Serina Tokita, Terufumi Kubo, Munehide Nakatsugawa, Takayuki Kanaseki, Tomohide Tsukahara, Yutaka Nakae, Osamu Sugita, Yoichi M. Ito, Yasunori Ota, Yasutoshi Kimura, Goro Kutomi, Koichi Hirata, Toru Mizuguchi, Kohzoh Imai, Ichiro Takemasa, Noriyuki Sato, Toshihiko Torigoe
Format: Artigo
Język:angielski
Wydane: 2019
Dostęp online:https://doi.org/10.1111/cas.14106
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cas.14106
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Internet

https://doi.org/10.1111/cas.14106
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cas.14106

Podobne zapisy